ロード中...
“The Google of Healthcare”: Enabling the privatization of genetic bio/databanking
PURPOSE: 23andMe is back on the market as the first direct-to-consumer genetic testing company that “includes reports that meet Food and Drug Administration (FDA) standards….” But, whereas its front-end product is selling individual genetic tests online, its back-end business model is amassing one o...
保存先:
| 出版年: | Ann Epidemiol |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6988384/ https://ncbi.nlm.nih.gov/pubmed/27449572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.annepidem.2016.05.007 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|